Glioblastoma Treatment in the Elderly in the Temozolomide Therapy Era
Linda Coate(University Health Network), Warren Mason(Princess Margaret Cancer Centre), Arjun Sahgal(Sunnybrook Health Science Centre), Mairéad G. McNamara(Australian and New Zealand Intensive Care Society), Ahmad Alzahrani(Princess Margaret Cancer Centre), Normand Laperrière(University Health Network), Cynthia Ménard(University of Toronto), Christine Massey(University of Vermont), Zarnie Lwin(The University of Queensland), Barbara Ann Millar(Princess Margaret Cancer Centre), Derek R. MacFadden(Princess Margaret Cancer Centre)
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
May 1, 2014
Cited by 6
Related Papers
Paraneoplastic anti– <i>N</i> ‐methyl‐ <scp>D</scp> ‐aspartate receptor encephalitis associated with ovarian teratoma
|Annals of Neurology|2007|2.5k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
|Journal of Clinical Oncology|2013|841